Guggenheim Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.3M Sell
299,878
-29,895
-9% -$6.96M 0.57% 27
2025
Q4
$68.2M Sell
329,773
-8,302
-2% -$1.64M 0.49% 33
2025
Q3
$62.7M Buy
338,075
+3,478
+1% +$596K 0.45% 36
2025
Q2
$51.1M Buy
334,597
+31,122
+10% +$4.78M 0.41% 48
2025
Q1
$50.3M Buy
303,475
+22,956
+8% +$3.59M 0.46% 42
2024
Q4
$40.6M Sell
280,519
-29,341
-9% -$4.55M 0.33% 60
2024
Q3
$50.2M Buy
309,860
+24,585
+9% +$3.92M 0.35% 51
2024
Q2
$41.7M Sell
285,275
-1,398
-0.5% -$208K 0.3% 63
2024
Q1
$45.3M Buy
286,673
+27,049
+10% +$4.31M 0.32% 56
2023
Q4
$40.7M Buy
259,624
+7,905
+3% +$1.21M 0.31% 54
2023
Q3
$39.2M Sell
251,719
-70,025
-22% -$11.6M 0.34% 55
2023
Q2
$53.3M Sell
321,744
-26,293
-8% -$4.24M 0.42% 33
2023
Q1
$53.9M Sell
348,037
-19,601
-5% -$3.17M 0.45% 28
2022
Q4
$64.9M Sell
367,638
-18,127
-5% -$3.13M 0.57% 16
2022
Q3
$63M Sell
385,765
-2,444
-0.6% -$414K 0.58% 18
2022
Q2
$68.9M Sell
388,209
-78,791
-17% -$14M 0.54% 20
2022
Q1
$82.8M Sell
467,000
-15,515
-3% -$2.64M 0.5% 24
2021
Q4
$82.5M Buy
482,515
+36,488
+8% +$5.97M 0.43% 32
2021
Q3
$72M Buy
446,027
+28,098
+7% +$4.79M 0.43% 26
2021
Q2
$68.8M Sell
417,929
-8,877
-2% -$1.47M 0.41% 26
2021
Q1
$70.1M Sell
426,806
-38,961
-8% -$6.3M 0.46% 25
2020
Q4
$73.3M Buy
465,767
+11,884
+3% +$1.75M 0.46% 24
2020
Q3
$67.6M Sell
453,883
-14,844
-3% -$2.2M 0.49% 19
2020
Q2
$65.9M Buy
468,727
+56,719
+14% +$8.27M 0.51% 18
2020
Q1
$54M Sell
412,008
-11,556
-3% -$1.64M 0.54% 15
2019
Q4
$61.8M Sell
423,564
-15,848
-4% -$2.15M 0.46% 24
2019
Q3
$56.9M Sell
439,412
-21,623
-5% -$2.85M 0.45% 22
2019
Q2
$64.2M Sell
461,035
-3,714
-0.8% -$514K 0.52% 16
2019
Q1
$65M Buy
464,749
+31,716
+7% +$4.25M 0.53% 14
2018
Q4
$55.9M Sell
433,033
-52,332
-11% -$7.3M 0.47% 19
2018
Q3
$67.1M Sell
485,365
-10,997
-2% -$1.46M 0.44% 18
2018
Q2
$60.2M Sell
496,362
-562,027
-53% -$70.1M 0.4% 20
2018
Q1
$136M Sell
1,058,389
-30,568
-3% -$4.13M 0.33% 16
2017
Q4
$152M Buy
1,088,957
+65,278
+6% +$9.09M 0.36% 11
2017
Q3
$133M Sell
1,023,679
-41,533
-4% -$5.51M 0.31% 18
2017
Q2
$141M Sell
1,065,212
-31,444
-3% -$4.01M 0.37% 8
2017
Q1
$137M Sell
1,096,656
-74,269
-6% -$8.87M 0.37% 6
2016
Q4
$135M Buy
1,170,925
+111,088
+10% +$12.8M 0.39% 6
2016
Q3
$125M Sell
1,059,837
-80,634
-7% -$9.78M 0.39% 8
2016
Q2
$138M Sell
1,140,471
-20,566
-2% -$2.34M 0.43% 7
2016
Q1
$126M Buy
1,161,037
+364
+0% +$37.7K 0.4% 8
2015
Q4
$119M Sell
1,160,673
-56,748
-5% -$5.71M 0.35% 14
2015
Q3
$114M Sell
1,217,421
-63,457
-5% -$6.14M 0.35% 12
2015
Q2
$125M Sell
1,280,878
-24,921
-2% -$2.5M 0.31% 16
2015
Q1
$131M Buy
1,305,799
+50,081
+4% +$5.09M 0.31% 16
2014
Q4
$131M Buy
1,255,718
+288,858
+30% +$30.4M 0.33% 14
2014
Q3
$103M Buy
966,860
+129,781
+16% +$13.5M 0.25% 26
2014
Q2
$87.6M Sell
837,079
-4,848
-0.6% -$490K 0.22% 51
2014
Q1
$82.7M Buy
841,927
+46
+0% +$4.26K 0.24% 47
2013
Q4
$77.1M Sell
841,881
-13,670
-2% -$1.26M 0.23% 47
2013
Q3
$74.2M Buy
855,551
+17,644
+2% +$1.58M 0.27% 33
2013
Q2
$71.9M Buy
+837,907
New +$71.1M 0.3% 24

Other funds holding JNJ

Guggenheim Capital's JNJ Position: Q1 2026 in Review

Guggenheim Capital reduced its Johnson & Johnson (JNJ) stake by 9.1% in Q1 2026, selling an estimated $6.96M and leaving 299,878 shares worth $73.3M. The position accounts for 0.57% of the portfolio, ranked #27.

Guggenheim Capital first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q4 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Guggenheim Capital held 299,878 shares of Johnson & Johnson worth $73.3M as of Q1 2026.
  • Guggenheim Capital sold 29,895 Johnson & Johnson shares in Q1 2026, an estimated $6.96M.
  • Johnson & Johnson made up 0.57% of Guggenheim Capital's portfolio in Q1 2026, its #27 holding.
  • Guggenheim Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Guggenheim Capital's Johnson & Johnson position peaked at $152M in Q4 2017.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.